Daniel Speciale is the vice president, investor relations and investor relations officer at Mallinckrodt Pharmaceuticals. He has responsibility for all investor relations interactions and activities for the company, and is a member of Mallinckrodt’s finance leadership team.
Mr. Speciale joined Mallinckrodt in 2013, with roles in investor relations, technical accounting and external reporting. Previously, Mr. Speciale held roles of increasing responsibility at PricewaterhouseCoopers.
Mr. Speciale holds a bachelor’s and master’s degree in accountancy from the Gies College of Business at the University of Illinois at Champaign-Urbana and is a Certified Public Accountant.